Alzheimer's disease (AD) is the most common neurodegenerative disease, characterized by deposits of amyloid-beta(A beta) peptides. However, the underlying molecular mechanisms of neuron cell dysfunction and cell death in AD still remain poorly understood. Yeast Saccharomyces cerevisiae shares many conserved biological processes with all eukaryotic cells, including human neurons. Thanks to relatively simple and quick genetic and environmental manipulations, the large knowledge base and data collections, this organism has become a valuable tool to unravel fundamental intracellular mechanisms underlying neurodegeneration. In this study, we have used yeast as a model system to study the effects of intracellular A beta peptides and we found that...
Alzheimer\u27s disease (AD) is a progressive neurodegenerative disorder characterized by acute cogni...
The yeast Saccharomyces cerevisiae, a unicellular eukaryotic model, has enabled major breakthroughs ...
Amyloid-beta (Aβ) plaques are a major neuropathological feature of Alzheimer's disease (AD). Th...
Alzheimer\u27s disease (AD) is the most common neurodegenerative disease, characterized by deposits ...
Alzheimer\u27s disease (AD) is a progressive neurodegeneration. Oligomers of amyloid-beta peptides (...
Alzheimer's disease (AD) is the most common form of dementia, and a devastating neurodegenerative di...
The 42 amino acid Alzheimer's A beta peptide is involved in the progression of Alzheimer's...
Ab (beta-amyloid peptide) is an important contributor to Alzheimer’s disease (AD). We modeled Ab tox...
Ab (beta-amyloid peptide) is an important contributor to Alzheimer’s disease (AD). We modeled Ab tox...
The 42 amino acid Alzheimer\u27s Aβ peptide is involved in the progression of Alzheimer\u27s di...
The 42 amino acid Alzheimer's Aβ peptide is involved in the progression of Alzheimer's disease. Here...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by acute cognitiv...
Alzheimer’s Disease (AD) is the most common neurodegenerative disorder. Brains from AD patients have...
The complexity of cellular pathways in neurodegenerative disease has limited the understanding of th...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by acute cog...
Alzheimer\u27s disease (AD) is a progressive neurodegenerative disorder characterized by acute cogni...
The yeast Saccharomyces cerevisiae, a unicellular eukaryotic model, has enabled major breakthroughs ...
Amyloid-beta (Aβ) plaques are a major neuropathological feature of Alzheimer's disease (AD). Th...
Alzheimer\u27s disease (AD) is the most common neurodegenerative disease, characterized by deposits ...
Alzheimer\u27s disease (AD) is a progressive neurodegeneration. Oligomers of amyloid-beta peptides (...
Alzheimer's disease (AD) is the most common form of dementia, and a devastating neurodegenerative di...
The 42 amino acid Alzheimer's A beta peptide is involved in the progression of Alzheimer's...
Ab (beta-amyloid peptide) is an important contributor to Alzheimer’s disease (AD). We modeled Ab tox...
Ab (beta-amyloid peptide) is an important contributor to Alzheimer’s disease (AD). We modeled Ab tox...
The 42 amino acid Alzheimer\u27s Aβ peptide is involved in the progression of Alzheimer\u27s di...
The 42 amino acid Alzheimer's Aβ peptide is involved in the progression of Alzheimer's disease. Here...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by acute cognitiv...
Alzheimer’s Disease (AD) is the most common neurodegenerative disorder. Brains from AD patients have...
The complexity of cellular pathways in neurodegenerative disease has limited the understanding of th...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by acute cog...
Alzheimer\u27s disease (AD) is a progressive neurodegenerative disorder characterized by acute cogni...
The yeast Saccharomyces cerevisiae, a unicellular eukaryotic model, has enabled major breakthroughs ...
Amyloid-beta (Aβ) plaques are a major neuropathological feature of Alzheimer's disease (AD). Th...